About Molecular HealthMolecular Health is a data and analytics driven precision medicine company. We capture, integrate, and analyze molecular outcomes data and clinical knowledge, to precisely identify treatments that target specific disease mechanisms.
Executive Chairman: Friedrich von Bohlen und Halbach, PhD
Chief Technology Officer: Stephan Brock, PhD
Chief Innovation Officer: David Jackson, PhD
Chief Operating Officer: Michael W. Hechler
Chief Information Officer: Rudolf Caspary, PhD
8 articles with Molecular Health
Molecular Health (MH), a leading company in the field of data science for precision medicine, today announced that the Company has signed up the HudsonAlpha Institute for Biotechnology (HudsonAlpha) as a new client for MH Guide.
Molecular Health, a leading company in the field of data science for precision medicine and specializing in the development of products and services leveraging its proprietary biomedicine technology platform Dataome, has been shortlisted for the German Digital Health Award 2019.
- Molecular Health Predict enables highly accurate estimates of clinical trial success probabilities - Exclusive license for the financial industry granted to DATEN CAPITAL - Molecular Health to receive an annual license fee and success-based payments
Molecular Health launches Molecular Health Guide 3.0, providing improved support for precision medicine
New features for intuitive biomarker classification and improved usability
Molecular Health receives grant from Bill & Melinda Gates Foundation
Agena Biosciences Announces Molecular Health As The First Interpretation Software Provider For MassARRAY Insights
Molecular Health Unveils New Decision Support Solutions For Clinical Interpretation Of Cancer Genome Data At AMP 2016 Annual Meeting